Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics Gets Quality Certification in US, Europe, and Japan

NEW YORK, May 18 (GenomeWeb News) - Hybrigenics, a Paris-based, a protein pathways-analysis company, has received global quality certification for its proteomics services, a public relations firm representing the firm said today.


According to Andrew Lloyd, the firm's spokesperson, Hybrigenics' services have obtained ISO 9001-2000 certification from the International Standards Organization in Europe, as well as certification from QMI, the standards registrar in the US, and from the Japan Quality Assurance Association, a non-profit standards registrar in that country.


Bart Kwist, the company's CEO, said the certifications would provide customers with "added confidence in the quality of the protein data" that the proteomics service provides. He said that few biotech companies have achieved such certification and that it would make Hybrigenics more competitive.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.